NSEMonitoring Agency ReportFundraise30 Oct 2026
GMR Power and Urban Infra Limited
Monitoring Agency Report
GMR Power and Urban Infra Limited has submitted a Monitoring Agency Report for the quarter ended September 30, 2026, regarding the utilization of proceeds from a preferential issue of Rs. 1200 crore.
BSECompany UpdateFundraise30 Oct 2026
GMR Power and Urban Infra Ltd
Monitoring Agency Report for the quarter ended September 30, 2026
GMR Power and Urban Infra Ltd has submitted a Monitoring Agency Report for the quarter ended September 30, 2026, as per SEBI regulations, detailing the utilization of funds raised through a preferential issue of equity shares and convertible warrants.
NSEIssue of SecuritiesFundraise30 Oct 2026
Sudarshan Pharma Industries Limited
Issue of Securities
Sudarshan Pharma Industries Limited has informed the Exchange about issue of Securities - The Board of Directors at its Meeting held on 29/Oct/2026 have approved the proposal to raising of funds through issue and allotment of Convertible Warrants upto an amount not exceeding Rs.72 Crores to Mr. Hemal Mehta and Mr. Sachin Mehta, Promoters of the Company.
BSECompany UpdateFundraise30 Oct 2026
Sudarshan Pharma Industries Ltd
In continuation of the Company''s letter dated 30/Oct/2026 (ref. no. SPIL/CS/2026-2027/72), the Board of Directors at its Meeting held on 29/Oct/2026 have approved the proposal to raising of funds through issue and allotment of Convertible Warrants upto an amount not exceeding Rs.72 Crores, each warrant convertible into 1 equity share of Re1/- each, on a preferential basis to Mr. Hemal Mehta and Mr. Sachin Mehta, Promoters of the Company.
The ....
Sudarshan Pharma Industries Ltd has approved a proposal to raise funds through the issue and allotment of Convertible Warrants worth up to Rs.72 Crores to its promoters, Mr. Hemal Mehta and Mr. Sachin Mehta, on a preferential basis.
BSECompany UpdateFundraise30 Oct 2026
Aanchal Ispat Ltd
pursuant to Regulation 30 of SEBI(LODR) Regulations, 2015 we wish to inform you that the board of Directors of the company at its meeting held today, i.e. 30.10.2026 has considered and approved allotment of 7,26,829 fully convertible warrants of face value of Rs.10/- each at an issue price of Rs.82/- per warrant to Mr. Mukesh Goel (Promoter of the company) on preferential basis as per applicable laws.
Aanchal Ispat Ltd has allotted 7,26,829 fully convertible warrants to its promoter, Mr. Mukesh Goel, at an issue price of Rs. 82 per warrant, aggregating to Rs. 5,95,99,978. The warrants are convertible into 1 fully paid-up equity share of the company and are payable in cash, with 25% of the issue price received upfront and the balance payable on exercise.
BSEGeneralFundraise30 Oct 2026
Aanchal Ispat Ltd
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at its meeting held today, i.e., Friday, October 30, 2026, has considered and approved the allotment of 7,26,829 Fully Convertible Warrants ("Warrants"), each convertible into 1 (one) fully paid-up equity share of the Company having a face value of Rs. 10/- (Rupees Ten only), ....
Aanchal Ispat Ltd has allotted 7,26,829 Fully Convertible Warrants to Mr. Mukesh Goel at an issue price of Rs. 82/- per Warrant, aggregating to Rs. 5,95,99,978/-, on a preferential basis.
BSECompany UpdateFundraise30 Oct 2026
Bizotic Commercial Ltd
Certificate of statement of Deviation
Bizotic Commercial Ltd has filed a certificate of statement of deviation for the utilization of funds raised through a preferential issue of 5,74,20,000 on April 2, 2026, with no deviation reported for the half year ended September 30, 2026.
BSECompany UpdateFundraise30 Oct 2026
Aptus Pharma Ltd
Receipt of In-Principle Approval for Preferential Issue
Aptus Pharma Ltd has received in-principle approval from BSE Ltd for a proposed preferential issue of equity shares, as approved by shareholders at their Annual General Meeting on September 14, 2026.
NSEGeneral UpdatesFundraise30 Oct 2026
Cubex Tubings Limited
General Updates
Cubex Tubings Limited has submitted a corrigendum to the notice of its Extra-Ordinary General Meeting (EGM) to provide additional disclosures and clarifications related to the proposed preferential issue of securities. The company plans to utilize 100% of the proceeds towards the procurement and installation of a vacuum melting furnace at its new manufacturing facility.
BSECompany UpdateFundraise30 Oct 2026
Rollatainers Ltd
Allotment of Convertible Equity Warrants
Rollatainers Ltd has announced the allotment of 22,42,15,245 convertible equity warrants at Rs. 2.23 per warrant, aggregating Rs. 49,99,99,997. The company has also approved a name change to 'AMAXIS GLOBAL LIMITED', alteration of the object clause, and shifting of its registered office. Additionally, the board has approved a related party transaction with Newtime Infrastructure Limited and a notice of postal ballot.
BSECompany UpdateFundraise30 Oct 2026
Medi Assist Healthcare Services Ltd
As enclosed
Medi Assist Healthcare Services Ltd has filed a statement of deviation or variation in the utilization of funds raised through a Preferential Issue for the quarter ended September 30, 2026. The company has reported no deviation or variation in the use of funds raised, as per the monitoring agency report issued by CARE Ratings Limited.
BSECompany UpdateFundraise30 Oct 2026
Kizi Apparels Ltd
Outcome of Board Meeting held on 30th October,2026 for Issue of Warrants on Preferential Basis
Kizi Apparels Ltd has announced the outcome of its board meeting, where it considered and approved the issuance of up to 51,69,000 warrants convertible into equity shares on a preferential basis. The warrants will be issued to promoters and public category investors at an issue price not less than the minimum price determined by SEBI ICDR Regulations. The company also approved the appointment of a registered valuer for determining the issue price of the warrants and fixed 30th October, 2026 as the relevant date for pricing the issue.
BSECompany UpdateFundraise30 Oct 2026
Medi Assist Healthcare Services Ltd
As enclosed
Medi Assist Healthcare Services Ltd has filed a statement of deviation or variation in the utilization of funds raised through a Preferential Issue for the quarter ended September 30, 2026. The company has confirmed that there has been no deviation or variation in the utilization of funds from the objects stated in the explanatory statement to the notice for the Preferential Issue. The Monitoring Agency Report issued by CARE Ratings Limited has been enclosed.
BSEGeneralFundraise30 Oct 2026
Rollatainers Ltd
Outcome of Board Meeting held today i.e. Friday, 30th October 2026
Rollatainers Ltd has announced the outcome of its board meeting, where it has approved the issue and allotment of 22,42,15,245 equity convertible warrants to promoters and non-promoters, alteration of the company's name to 'Amaxis Global Ltd', and other business matters.
NSEMonitoring Agency ReportFundraise30 Oct 2026
Medi Assist Healthcare Services Limited
Monitoring Agency Report
Medi Assist Healthcare Services Limited has filed a statement of deviation or variation in the utilization of funds raised through a Preferential Issue for the quarter ended September 30, 2026. The company has reported no deviation or variation in the use of funds raised, as per the monitoring agency report issued by CARE Ratings Limited.
NSEOutcome of Board MeetingFundraise30 Oct 2026
Rollatainers Limited
Outcome of Board Meeting
Rollatainers Limited has informed the Exchange regarding Outcome of Board Meeting held on October 30, 2026. The Board has approved the issue and allotment of 22,42,15,245 equity convertible warrants, change of the Company’s name from “ROLLATAINERS LIMITED” to “AMAXIS GLOBAL LIMITED”, alteration of the Object Clause of the Memorandum of Association, shifting of Registered Office, approval of related party transaction and approval of Notice of Postal Ballot.
BSEAGM/EGMFundraise30 Oct 2026
Cubex Tubings Ltd
With reference to the Notice of Extra-Ordinary General Meeting (EGM) of the Company scheduled to be held on November 6, 2026, and pursuant to the observations/queries received from BSE Limited and the National Stock Exchange of India Limited, we hereby submit the Corrigendum to the said EGM Notice.
The Corrigendum contains certain clarifications and additional disclosures in relation to the proposed preferential issue, in accordance with the applicable ....
Cubex Tubings Ltd has submitted a Corrigendum to the Notice of Extra-Ordinary General Meeting (EGM) in relation to the proposed preferential issue of securities, providing additional disclosures and clarifications.
NSEAllotment of SecuritiesFundraise30 Oct 2026
Rollatainers Limited
Allotment of Securities
Rollatainers Limited has informed the Exchange regarding allotment of 224215245 Equity convertible warrants pursuant to Preferential Issue at its meeting held on October 30, 2026. The company has also approved related party transaction with Newtime Infrastructure Limited, change of name, alteration of object clause, and shifting of registered office.
BSEResultFundraise30 Oct 2026
Kizi Apparels Ltd
Unaudited Stanalone Financial Result of the company for the Half year ended on 30th September, 2026
Kizi Apparels Ltd has announced unaudited standalone financial results for the half year ended 30th September, 2026, and plans to issue up to 51,69,000 warrants convertible into equity shares on a preferential basis to promoters and public category investors.
BSECompany UpdateFundraise30 Oct 2026
Emrock Corporation Ltd
Board of Directors of the company on October 10, 2026 allotted 55,00,000 Equity Shares of Rs. 10 each at a premium of Rs. 1 per shares pursuant to conversion of 55,00,000 warrants issued on May 10, 2025. Furhter details as per Regulations attached herewith.
Emrock Corporation Ltd has allotted 55,00,000 equity shares of Rs. 10 each at a premium of Rs. 1 per share pursuant to conversion of 55,00,000 warrants issued on May 10, 2025. The issued, subscribed, and paid-up equity share capital of the company has increased from Rs. 15,82,00,000 to Rs. 21,32,00,000.